Literature DB >> 4621747

Inhibition of cold agglutinins (anti-I) by M. pneumoniae antigens.

N Costea, V J Yakulis, P Heller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4621747     DOI： 10.3181/00379727-139-36167

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  7 in total

1.  Agglutinins against human erythrocytes modified by Newcastle disease virus in Mycoplasma pneumoniae infections.

Authors:  K Aho; R Pyhälä
Journal:  Clin Exp Immunol       Date:  1974-08       Impact factor: 4.330

2.  Isolation, characterization, and biological properties of an endotoxin-like material from the gram-positive organism Listeria monocytogenes.

Authors:  H Wexler; J D Oppenheim
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

Review 3.  IVIG in the treatment of children with acute and chronic idiopathic thrombocytopenic purpura and the autoimmune cytopenias.

Authors:  D J Nugent
Journal:  Clin Rev Allergy       Date:  1992 Spring-Summer

4.  [High titer cold agglutinins with anti-pr specificity after rubella infection (author's transl)].

Authors:  H P Geisen; D Roelcke; K Rehn; G Konrad
Journal:  Klin Wochenschr       Date:  1975-08-15

Review 5.  The use of organ cultures and animal models in the study of Mycoplasma pneumoniae infections.

Authors:  D Taylor-Robinson
Journal:  Infection       Date:  1976       Impact factor: 3.553

6.  Evidence for occurrence of passively adsorbed I antigen activity on a cultured strain of Mycoplasma pneumoniae.

Authors:  K Uemura; L M Loomes; R A Childs; T Feizi
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

7.  Serological diagnosis of Mycoplasma pneumoniae infection by enzyme immunoassay.

Authors:  S M Räisänen; J I Suni; P Leinikki
Journal:  J Clin Pathol       Date:  1980-09       Impact factor: 3.411
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.